Archon
Seattle, US · 5 known investors
Archon Biosciences develops a computational protein design platform leveraging AI and deep learning for therapeutic and vaccine applications. The company was founded in 2023 by James Lazarovits and George Ueda, Ph.D., building on research in AI-driven protein engineering and nanomaterial delivery.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
GU
George Ueda, Ph.D.Chief Technology Officer, Co-Founder
JL
James Lazarovits, Ph.D.Chief Executive Officer, Co-Founder
Investors · 5
In the news
- Chinese Embodied Intelligence Company Archon Robotics Secures Hundreds of Millions in Seed Funding - Wedoanyen.wedoany.com · 2026
- Archon Robotics closes record seed round to build foundation model - The Yangtzeeryangtzeer.com · 2026
- Seeds | Archon Robotics, a General Whole-Body Embodied Intelligence Developer, Raises Hundreds of Millions in Seed Round | Gasgooautonews.gasgoo.com · 2026
- Archon - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2025
- Archon Biosciences Emerges from Stealth to Advance a New Class of Biologic Invented in Nobel Prize-Winning Computational Protein Design Lab — Archon Bioarchon.bio · 2024
- Archon Biosciences Raises $20M in Seed Fundingfinsmes.com · 2024